![]() ![]() ![]() … but as you know, that discussion never really gained traction outside the chorus. The epidemic sucked the air (conscious pun) out of almost all other human endeavors, including, for a time, other aspects of biomedicine - and longevity therapeutics was a fragile sector that was only beginning to establish itself.Ĭertainly, we and others have been endeavoring to hammer home the point that the widely-recognized massive increase in risk of death with age from the disease should not simply be taken as a law of nature, but is *itself* susceptible to medical intervention that could ameliorate or abrogate the age effect, taming COVID and nearly all other infectious disease affecting adults: ![]() I was really afraid through most of 2020 that the pandemic was really going to set the entire longevity therapeutics space back and that we would not only come out of it weaker but be unable to bounce back in the way that most sectors would do (and some spectacularly). Lifespan.io: Second, in the last year, are you more or less optimistic of us doing so and why? ![]()
0 Comments
Leave a Reply. |